Delivery Order SPE2DB22D3301-SPE2DB25FX4GH
Award Date
10/23/24
Potential Completion Date
10/24/24
Potential Value
$10K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of OGIVRI 420 MG VIALS, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $10,609.71, has an ultimate completion date of July 2, 2024. It is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary...
This federal contract award to AmerisourceBergen Drug Corp (ABDC) is a delivery order valued at $10,886.20 for the supply of OGIVRI 420 MG VIALS. The contract has an ultimate completion date of April 4, 2025 and was awarded on April 3, 2025 by the Defense Logistics Agency (DLA), a defense agency. The contract is a firm fixed-price, non-set-aside agreement that is part of a larger Indefinite Delivery Contract (IDC) worth $999,999,999 between ABDC and the DLA Troop Support Medical. This IDC serves...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $3,324.97 firm fixed price contract is for the delivery of 4563372089 OGIVRI 420 MG vials. The contract has a completion date of January 22, 2024 and was awarded on January 19, 2024. There was no set-aside designation used for this award. Amerisourcebergen Drug Corp has...
This federal contract award, valued at $5,297.75, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order worth $10,844.44 for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of March 3, 2025. The contract is a firm fixed-price type with no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award is a delivery order valued at $2,241.90 awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for medical products, including "INJECTOR DRG DLV BD PHASEAL IV LL N35 LF", with a completion date of January 16, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through...
This federal contract award is a delivery order valued at $8,505.80 awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, issued by the Defense Logistics Agency (DLA), is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract covers a variety of critical medical...
This federal contract award, valued at $1,942.00, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under the company's existing Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of...
This federal contract award is a delivery order valued at $17,135.66 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of PRIORIX VIALS, a pharmaceutical product, with a completion date of November 27, 2024. The contract is a firm fixed-price agreement with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999...
This federal contract award, valued at $5,503.40, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support...